|
||
“No Need for Routine Pelvic Exams.” By Charles Bankhead, MedPage Today. Average-risk, asymptomatic women do not benefit from pelvic exams as part of routine care and face potential harms from false-positive results, according to a new clinical guideline. A review of more than 60 years’ worth of medical literature did not produce compelling evidence that . . . → Read More: No Need for Routine Pelvic Exams
“What the Reduction in Tonsillectomies Teaches Us About Medicine.” By Aaron Carroll, The New York Times. When I was a child, one of my favorite books was “Curious George Goes to the Hospital.” It told the story of a little monkey who swallowed a puzzle piece, needed an operation to . . . → Read More: What the Reduction in Tonsillectomies Teaches Us About Medicine
“Which journalists reported an extra dimension on the 3-D mammography story?”By Gary Schwitzer, Health News Review. Faithful to the latest journal article, many news organizations dutifully reported what they were told by authors of a study published in the Journal of the American Medical Association, “Breast Cancer Screening Using Tomosynthesis in Combination with Digital Mammography.“ . . . → Read More: Which journalists reported an extra dimension on the 3-D mammography story?
“‘Nothing Is Broken’: For An Injured Doctor, Quality-Focused Care Misses The Mark.’” By Charlotte Yeh, Health Affairs. When a physician winds up in the emergency department, providers put quality metrics and testing before her actual needs. It was just after 6 o’clock in the evening on Wednesday, December 7, 2011—Pearl Harbor Day—when I left my . . . → Read More: Quality-Focused Care Misses The Mark
“Review: Decoding Annie Parker.” The Risky Body blog. Decoding Annie Parker tells the story of two women; Annie Parker, a three time cancer survivor and the geneticist Mary-Claire King whose discovery of the breast cancer BRCA gene mutation is considered one of the most important discoveries of the 20th century. I see why BRCA+ women . . . → Read More: Review: Decoding Annie Parker
“ASCO: Herceptin Still a Boon for Small Breast Tumors.” By Michael Smith, MedPage Today. The monoclonal antibody trastuzumab (Herceptin) was beneficial for women with small tumors, according to a new meta-analysis of the randomized trials of the drug. It also was equally beneficial in hormone receptor-positive and -negative disease, according to Ciara O’Sullivan, MD, of . . . → Read More: ASCO: Herceptin Still a Boon for Small Breast Tumors
“Study: Costly Breast Cancer Treatment More Common At For-Profit Hospitals.” By Roni Caryn Rabin, Kaiser Health News. Research funded by the National Cancer Institute and the Robert Wood Johnson Foundation published in the May issue of the journal Surgery finds that “reimbursement is a significant driver of the adoption of new cancer therapies.” Dr. Cary . . . → Read More: Study: Costly Breast Cancer Treatment More Common At For-Profit Hospitals
“Mammograms: overrated – and over-diagnosing women.” By Karuna Jaggar, The Guardian. How will we ever hope to make desperately needed progress in the breast cancer crisis when the mainstream breast cancer movement continues to push an outdated and scientifically debunked agenda? The evidence has been mounting that the time has come to radically re-think the . . . → Read More: Mammograms: overrated – and over-diagnosing women
“Former Technician Rachael Rapraeger Falsified Mammogram Reports.” NBC News. Radiological technologist at Perry Hospital a small community about 100 miles south of Atlanta pleaded guilty earlier this month to 10 misdemeanor charges of reckless conduct and one felony charge of computer forgery related to falsifying mammogram reports. She was sentenced to serve up to six . . . → Read More: Former Radiology Technician Falsified Mammogram Reports
“The Art of Risk Communication: Breast cancer screening pamphlets mislead women” by Gerd Gigerenzer, British Medical Journal. “All women and women’s organisations should tear up the pink ribbons and campaign for honest information.” Why should I have mammography? That question is regularly asked in pamphlets for screening. The answer is also regularly misleading. Women . . . → Read More: Breast cancer screening pamphlets mislead women |
||
| Copyright © 2026 Breast Cancer Consortium – Archives - All Rights Reserved. Privacy Policy | ||